126 related articles for article (PubMed ID: 15301685)
41. Simultaneous detection of hepatitis C virus core antigen and antibodies in Saudi drug users using a novel assay.
Alzahrani AJ
J Med Virol; 2008 Apr; 80(4):603-6. PubMed ID: 18297713
[TBL] [Abstract][Full Text] [Related]
42. Prediction of viremia for cases of hepatitis C virus (HCV) infection using a third-generation anti-HCV enzyme immunoassay test.
Huang WS; Lu SN; Wang JH; Lee CM; Tung HD; Chen TM; ChangChien CS
Hepatogastroenterology; 2005; 52(63):893-6. PubMed ID: 15966227
[TBL] [Abstract][Full Text] [Related]
43. Consecutive infections and clearances of different hepatitis C virus genotypes in an injecting drug user.
Aitken CK; Tracy SL; Revill P; Bharadwaj M; Bowden DS; Winter RJ; Hellard ME
J Clin Virol; 2008 Apr; 41(4):293-6. PubMed ID: 18242125
[TBL] [Abstract][Full Text] [Related]
44. Hepatitis C virus infection acquired in childhood.
Camarero C; Ramos N; Moreno A; Asensio A; Mateos ML; Roldan B
Eur J Pediatr; 2008 Feb; 167(2):219-24. PubMed ID: 17464514
[TBL] [Abstract][Full Text] [Related]
45. High prevalence of HBV and HCV infection among intravenous drug users in Korea.
Yun H; Kim D; Kim S; Kang S; Jeong S; Cheon Y; Joe K; Gwon DH; Cho SN; Jee Y
J Med Virol; 2008 Sep; 80(9):1570-5. PubMed ID: 18649342
[TBL] [Abstract][Full Text] [Related]
46. Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy.
Mast EE; Hwang LY; Seto DS; Nolte FS; Nainan OV; Wurtzel H; Alter MJ
J Infect Dis; 2005 Dec; 192(11):1880-9. PubMed ID: 16267758
[TBL] [Abstract][Full Text] [Related]
47. Hepatitis C virus (HCV)--specific T cell responses in injection drug users with apparent resistance to HCV infection.
Thurairajah PH; Hegazy D; Chokshi S; Shaw S; Demaine A; Kaminski ER; Naoumov NV; Cramp ME
J Infect Dis; 2008 Dec; 198(12):1749-55. PubMed ID: 18959498
[TBL] [Abstract][Full Text] [Related]
48. Post-transplant recurrent hepatitis C: immunohistochemical detection of hepatitis C virus core antigen and possible pathogenic implications.
Pessôa MG; Alves VA; Wakamatsu A; Gomes JG; Maertens G; van der Borght B; Kim M; Ferrell L; Wright TL
Liver Int; 2008 Jul; 28(6):807-13. PubMed ID: 18422936
[TBL] [Abstract][Full Text] [Related]
49. [Vertical transmission of hepatitis C virus].
Fang Z; Masashi M; Zhang X; Liu X; Wu R; Wang D; Su P; Zhou Z; Tang Y; Li A
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Jun; 11(2):130-3. PubMed ID: 15619817
[TBL] [Abstract][Full Text] [Related]
50. Hepatitis C virus antibodies in homosexual men and intravenous drug users in Denmark.
Westh H; Worm AM; Jensen BL; Kroon S; Kvinesdal B; Nielsen CM; Wantzin P
Infection; 1993; 21(2):115-7. PubMed ID: 7684028
[TBL] [Abstract][Full Text] [Related]
51. HCV antibody quantitative levels in liver transplant patients: do they have any relevance in clinical practice?
Jain A; Menegus M; Mohanka R; Orloff M; Abt P; Mantry P; Bozorgzadeh A
Exp Clin Transplant; 2006 Jun; 4(1):475-80. PubMed ID: 16827647
[TBL] [Abstract][Full Text] [Related]
52. High prevalence of hepatitis C virus infection in the largest province of Pakistan.
Idrees M; Lal A; Naseem M; Khalid M
J Dig Dis; 2008 May; 9(2):95-103. PubMed ID: 18419643
[TBL] [Abstract][Full Text] [Related]
53. Hepatitis B and C virus coinfection in The TREAT Asia HIV Observational Database.
Zhou J; Dore GJ; Zhang F; Lim PL; Chen YM;
J Gastroenterol Hepatol; 2007 Sep; 22(9):1510-8. PubMed ID: 17645479
[TBL] [Abstract][Full Text] [Related]
54. Detection of hepatitis C virus (HCV) RNA in the liver of healthy, anti-HCV antibody-positive, serum HCV RNA-negative patients with normal alanine aminotransferase levels.
Carreño V; Pardo M; López-Alcorocho JM; Rodríguez-Iñigo E; Bartolomé J; Castillo I
J Infect Dis; 2006 Jul; 194(1):53-60. PubMed ID: 16741882
[TBL] [Abstract][Full Text] [Related]
55. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia.
Maher L; Chant K; Jalaludin B; Sargent P
J Gastroenterol Hepatol; 2004 Oct; 19(10):1114-20. PubMed ID: 15377287
[TBL] [Abstract][Full Text] [Related]
56. [Evaluation of the patients with low levels of anti-HCV positivity].
Zer Y; Karaoğlan I; Ciçek H; Karağoz ID; Sağlam M
Mikrobiyol Bul; 2009 Jan; 43(1):133-9. PubMed ID: 19334390
[TBL] [Abstract][Full Text] [Related]
57. Benefits and adverse effects of hepatitis C screening: early results of a screening program.
Trepka MJ; Zhang G; Leguen F; Obiaja K; Malow RM; De La Rosa M
J Public Health Manag Pract; 2007; 13(3):263-9. PubMed ID: 17435493
[TBL] [Abstract][Full Text] [Related]
58. Mother to child transmission of hepatitis C virus: rate of infection and risk factors.
Syriopoulou V; Nikolopoulou G; Daikos GL; Theodoridou M; Pavlopoulou I; Nicolaidou P; Manolaki N
Scand J Infect Dis; 2005; 37(5):350-3. PubMed ID: 16051571
[TBL] [Abstract][Full Text] [Related]
59. Sensitivity of second-generation enzyme immunoassay for detection of hepatitis C virus infection among oncology patients.
Macedo de Oliveira A; White KL; Beecham BD; Leschinsky DP; Foley BP; Dockter J; Giachetti C; Safranek TJ
J Clin Virol; 2006 Jan; 35(1):21-5. PubMed ID: 15921955
[TBL] [Abstract][Full Text] [Related]
60. Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan.
Liu JY; Lin HH; Liu YC; Lee SS; Chen YL; Hung CC; Ko WC; Huang CK; Lai CH; Chen YS; Shih YL; Chung HC; Liang SH; Lin JN
Clin Infect Dis; 2008 Jun; 46(11):1761-8. PubMed ID: 18433337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
